No profile data available.
Vivos Therapeutics, Inc. (VVOS) is a healthcare company in the targeted healthcare equipment industry, based in Littleton, United States, with about 268 full-time employees.
It reported revenue of $17.44 million for fiscal year 2025, up 16.0% from fiscal year 2024, and net income of -$21.23 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $5.15 million, up 34.9% from a year before. Its market capitalization was $5.00 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults.
Vivos Therapeutics reported $17.44 million in revenue for fiscal year 2025, up 16.0% from $15.03 million in fiscal year 2024. In Q2 2026 revenue was $5.15 million.
$5.00 million as of October 9, 2026.
Listed companies of a similar size in the same industry (targeted healthcare equipment) include enVVeno Medical Corporation (NVNO), Autonomix Medical, Inc. (AMIX), IceCure Medical Ltd (ICCM), Phaos Technology Holdings (Cayman) Limited (POAS).